Results 221 to 230 of about 9,352,293 (347)
Advancing Extracellular Vesicle Research: A Review of Systems Biology and Multiomics Perspectives
ABSTRACT Extracellular vesicles (EVs) are membrane‐bound vesicles secreted by various cell types into the extracellular space and play a role in intercellular communication. Their molecular cargo varies depending on the cell of origin and its functional state.
Gloria Kemunto +2 more
wiley +1 more source
Primary Gastrointestinal EBV-Associated Classical Hodgkin Lymphoma in Crohn Disease on Anti-TNF-α Therapy: A Rare Association. [PDF]
Collins K, Toklu A, Dave N, Mesa H.
europepmc +1 more source
Vedolizumab as induction and maintenance therapy for Crohn's disease.
W. Sandborn +16 more
semanticscholar +1 more source
Abstract Mirikizumab is a p19‐directed anti‐interleukin‐23 antibody approved for the treatment of adults with moderate‐to‐severe ulcerative colitis (UC). Here, we report the first data of mirikizumab pharmacokinetics (PK) and exposure–response (E/R) relationships in pediatric participants (aged 2 to <18 years weighing >10 kg) with moderate‐to‐severe UC
Yuki Otani +5 more
wiley +1 more source
A bidirectional Mendelian randomization study of spleen volume and Crohn disease. [PDF]
Song HH, Zhang HR, Hu XR, Jiang XC.
europepmc +1 more source
Biomimetic nanocarriers based on liposomes and Myxobacteria outer‐membrane vesicles (OMVs) are effective antibiotic delivery systems. Hybrids have a higher drug loading and can target intracellular pathogens, while OMVs evade immune clearance. Biomimetic nanoantibiotics effectively eliminate the biofilms of Gram‐negative bacteria. Besides, Myxobacteria
Leila Pourtalebi Jahromi +13 more
wiley +1 more source
Pediatric Crohn Disease Presenting as Isolated Acute Upper-GI Bleed: A Case Report. [PDF]
Norris L +8 more
europepmc +1 more source
Enteral nutritional therapy for induction of remission in Crohn's disease.
N. Narula +5 more
semanticscholar +1 more source

